Adjuvant chemotherapy for oesophagogastric cancer with epirubicin, cisplatin and infusional 5-fluorouracil (ECF): a Royal Marsden pilot study.

Previous trials of adjuvant chemotherapy for oesophagogastric cancer have shown only modest or no improvement in survival. However, the regimens used in these studies produce low response rates in patients with advanced disease. ECF is a new regimen which results in higher response rates and may the...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Bamias, A., Cunningham, D., Nicolson, V., Norman, A., Hill, M., Nicolson, M., O'Brien, M., Webb, A., Hill, A.
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 1995
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2033623/
https://ncbi.nlm.nih.gov/pubmed/7880742
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares